Plasmodium vivax is the most widely distributed of several plasmodial species that cause human malaria, a disease associated with blood-stage parasite replication. About 2.5 billion people are at risk of P. vivax infection; they live mainly in Southeast Asia and the Americas, where P. vivax accounts for approximately 72% of malaria cases.
Day 3: Friday, 28th June
Wrapping up the 7th International Conference on Plasmodium vivax Research, day three focused on the topics of P. vivax drugs and approaches for P. vivax elimination.
Day 2: Thursday, 27th June
The main focus of the presentations on day two of the 7th International Conference on Plasmodium vivax Research was on laboratory exploration of P. vivax biological characteristics, parasite development stages and host-parasite interaction. There was a lively poster session during the lunch period and a conference dinner at the magnificent Musée d’Orsay.
Day 1: Wednesday, 26th June
2018 was the first year of the RBM Partnership to End Malaria’s 2018–2020 Strategic Plan (see page 7), which aims to use the partnership to boost political commitment, regional cooperation and malaria financing. The Partnership, through consultations with partners and malaria-endemic countries, launched new initiatives in support of global efforts to end malaria.
Event: Malaria in Melbourne 2019 Conference
Date: October 28–29, 2019
Location: Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
Creating a malaria-free world is a bold and important public health and sustainable development goal. It is also the vision of the Global technical strategy for malaria 2016-2030, which calls for the elimination of malaria in at least 10 countries by the year 2020.
In 2016, WHO identified 21 countries, spanning 5 regions, that could defeat malaria by 2020, considering the likelihood of elimination across key criteria. All are united by one target: to achieve zero indigenous cases of malaria within the 2020 timeline. This report charts their progress.
The MESA Correspondent volunteers report on the latest in malaria research from conferences around the world. The synopses are shared online, enabling people who could not attend the meeting to read about the latest advances. The MESA Correspondents Program is a collaboration between MESA and the conference organizers.
Two review authors independently assessed trials for eligibility, analyzed risk of bias, and extracted data. We used risk ratio (RR) and 95% confidence intervals (CI). We stratified by type of insecticide: ‘non‐pyrethroid‐like', as this could improve malaria control better than adding IRS insecticides that have the same way of working as the insecticide on ITNs (‘pyrethroid‐like'). We used subgroup analysis of ITN usage in the trials to explore heterogeneity. We assessed the certainty of evidence using the GRADE approach.
Malaria Minute, 14 June 2019
Big data allows scientists to produce malaria ‘risk maps’ in Bangladesh and Indian researchers develop a new paper-based method of malaria detection.